Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Epilepsy

Free Subscription Articles published in Brain Dev Retrieve available abstracts of 87 articles: HTML format

Single Articles

April 2024
1. SILVA S, Rosas M, Guerra B, Munoz M, et al
   Adolescent-onset epilepsy and deterioration associated with CAD deficiency: A case report.
   Brain Dev. 2024 Apr 18:S0387-7604(24)00057.
   PubMed     Abstract available
   
   
   March 2024
2. TAKEUCHI H, Higurashi N, Toga Y
   Prophylactic antiseizure medications for recurrent status epilepticus in nonsyndromic childhood epilepsy.
   Brain Dev. 2024 Mar 21:S0387-7604(24)00043.
   PubMed     Abstract available
   
   
   
3. YUKSEL MF, Dogulu N, Yildirim M, Kose E, et al
   Metabolic etiologies in children with infantile epileptic spasm syndrome: Experience at a tertiary pediatric neurology center.
   Brain Dev. 2024 Mar 16:S0387-7604(24)00042.
   PubMed     Abstract available
   
   
   January 2024
4. AKIYAMA T, Saigusa D, Inoue T, Tokorodani C, et al
   Exploration of urine metabolic biomarkers for new-onset, untreated pediatric epilepsy: A gas and liquid chromatography mass spectrometry-based metabolomics study.
   Brain Dev. 2024 Jan 2:S0387-7604(23)00209-7. doi: 10.1016/j.braindev.2023.
   PubMed     Abstract available
   
   
   December 2023
5. NISHIOKA M, Motobayashi M, Fukuyama T, Inaba Y, et al
   Risk factors for post-encephalopathic epilepsy in patients with acute encephalopathy with biphasic seizures and late reduced diffusion.
   Brain Dev. 2023 Dec 18:S0387-7604(23)00194.
   PubMed     Abstract available
   
   
   
6. DE KNEGT VE, Borresen ML, Knudsen M, Thomsen KM, et al
   Current state of hemispherectomy and callosotomy for pediatric refractory epilepsy in Denmark.
   Brain Dev. 2023 Dec 2:S0387-7604(23)00179-1. doi: 10.1016/j.braindev.2023.
   PubMed     Abstract available
   
   
   November 2023
7. DILENA R, Striano P, Traverso M, Viri M, et al
   Corrigendum to "Dramatic effect of levetiracetam in early-onset epileptic encephalopathy due to STXBP1 mutation" [Brain Dev. 38(1) (2016) 128-131].
   Brain Dev. 2023 Nov 24:S0387-7604(23)00176.
   PubMed    
   
   
   
8. ANUAR MA, Lee JX, Musa H, Abd Hadi D, et al
   Severe and rare neurological manifestations following COVID-19 infection in children: A Malaysian tertiary centre experience.
   Brain Dev. 2023;45:547-553.
   PubMed     Abstract available
   
   
   
9. AMORE G, Cali E, Spano M, Ceravolo G, et al
   ATP6V1B2-related disorders featuring Lennox-Gastaut-syndrome: A case-based overview.
   Brain Dev. 2023;45:588-596.
   PubMed     Abstract available
   
   
   October 2023
10. UEDA Y, Furugen A, Kobayashi M, Sato Y, et al
    Use of lacosamide for focal epilepsy in a child with kidney failure undergoing peritoneal dialysis.
    Brain Dev. 2023 Oct 30:S0387-7604(23)00156.
    PubMed     Abstract available
    
    
    
11. WATANABE Y, Yamanaka G, Morichi S, Hayashi K, et al
    Altered serum levels of platelet-derived growth factor receptor beta and cluster of differentiation 13 suggest a role for pericytes in West syndrome.
    Brain Dev. 2023;45:479-486.
    PubMed     Abstract available
    
    
    September 2023
12. DAI L, Ding C, Tian X, Liu M, et al
    The clinical spectrum associated with ATP1A2 variants in Chinese pediatric patients.
    Brain Dev. 2023;45:422-431.
    PubMed     Abstract available
    
    
    August 2023
13. SHIRAISHI H, Egawa K, Murakami K, Nakajima M, et al
    Transcutaneous auricular vagus nerve stimulation therapy in patients with cognitively preserved structural focal epilepsy: A case series report.
    Brain Dev. 2023 Aug 30:S0387-7604(23)00148.
    PubMed     Abstract available
    
    
    
14. AKIYAMA M, Akiyama T, Saitsu H, Tokioka Y, et al
    A female patient with adolescent-onset progressive myoclonus epilepsy carrying a truncating MECP2 mutation.
    Brain Dev. 2023 Aug 5:S0387-7604(23)00116-X. doi: 10.1016/j.braindev.2023.
    PubMed     Abstract available
    
    
    
15. SANO K, Miya F, Kato M, Omata T, et al
    Neurochemistry evaluated by magnetic resonance spectroscopy in a patient with FBXO28-related developmental and epileptic encephalopathy.
    Brain Dev. 2023 Aug 3:S0387-7604(23)00113-4. doi: 10.1016/j.braindev.2023.
    PubMed     Abstract available
    
    
    July 2023
16. OKUBO Y, Shibuya M, Nakamura H, Kawashima A, et al
    Neonatal developmental and epileptic encephalopathy with movement disorders and arthrogryposis: A case report with a novel missense variant of SCN1A.
    Brain Dev. 2023 Jul 11:S0387-7604(23)00110.
    PubMed     Abstract available
    
    
    June 2023
17. KOBAYASHI Y, Honda R, Yamada K, Hojo M, et al
    Two-year efficacy of lacosamide as adjunctive therapy for generalized tonic-clonic seizures in patients with juvenile myoclonic epilepsy.
    Brain Dev. 2023 Jun 10:S0387-7604(23)00091.
    PubMed     Abstract available
    
    
    
18. ROSSI J, Russo M, Gobbi G, Terracciano A, et al
    Developmental and epileptic encephalopathy in a young Italian woman with a de novo missense variant in the CLCN4 gene: A case report.
    Brain Dev. 2023 Jun 2:S0387-7604(23)00088-8. doi: 10.1016/j.braindev.2023.
    PubMed     Abstract available
    
    
    
19. HANAFUSA H, Yamaguchi H, Kondo H, Nagasaka M, et al
    Dravet syndrome and hemorrhagic shock and encephalopathy syndrome associated with an intronic deletion of SCN1A.
    Brain Dev. 2023;45:317-323.
    PubMed     Abstract available
    
    
    April 2023
20. STUDER M, Schmitt S, Wingeier K, Lidzba K, et al
    Delayed episodic memory recall after one week is associated with executive functions and divided attention in pediatric epilepsy patients.
    Brain Dev. 2023 Apr 8:S0387-7604(23)00065-7. doi: 10.1016/j.braindev.2023.
    PubMed     Abstract available
    
    
    March 2023
21. MORI T, Sakamoto M, Tayama T, Goji A, et al
    A case of epilepsy with myoclonic atonic seizures caused by SLC6A1 gene mutation due to balanced chromosomal translocation.
    Brain Dev. 2023 Mar 23:S0387-7604(23)00044.
    PubMed     Abstract available
    
    
    
22. SUN S, Li X, Liu X
    Efficacy, tolerability and safety of perampanel in children and adolescents with epilepsy: Systematic review and meta-analysis.
    Brain Dev. 2023 Mar 4:S0387-7604(23)00040-2. doi: 10.1016/j.braindev.2023.
    PubMed     Abstract available
    
    
    
23. SHIRAISHI H, Teramoto T, Yokoshiki S, Tohyama J, et al
    Efficacy of sirolimus for epileptic seizures in childhood associated with focal cortical dysplasia type II.
    Brain Dev. 2023 Mar 2:S0387-7604(23)00028-1. doi: 10.1016/j.braindev.2023.
    PubMed     Abstract available
    
    
    
24. POLITANO D, Gana S, Pezzotti E, Berardinelli A, et al
    A novel variant in NEUROD2 in a patient with Rett-like phenotype points to Glu130 codon as a mutational hotspot.
    Brain Dev. 2023;45:179-184.
    PubMed     Abstract available
    
    
    February 2023
25. OZKAN KART P, Citli S, Yildiz N, Cansu A, et al
    A novel INPP4A mutation with pontocerebellar hypoplasia, myoclonic epilepsy, microcephaly, and severe developmental delay.
    Brain Dev. 2023 Feb 7:S0387-7604(23)00019-0. doi: 10.1016/j.braindev.2023.
    PubMed     Abstract available
    
    
    
26. YAMAMOTO Y, Ohta A, Usui N, Imai K, et al
    Clinical value of therapeutic drug monitoring for levetiracetam in pediatric patients with epilepsy.
    Brain Dev. 2023 Feb 7:S0387-7604(23)00020-7. doi: 10.1016/j.braindev.2023.
    PubMed     Abstract available
    
    
    
27. WATANABE Y, Odaka M, Motoi H, Oyama Y, et al
    Neurological prognostic factors for human herpes virus 6/7-associated acute encephalopathy in children: A single-center study.
    Brain Dev. 2023;45:102-109.
    PubMed     Abstract available
    
    
    January 2023
28. BONARDI CM, Furlanis GM, Toldo I, Guarrera B, et al
    Myoclonic super-refractory status epilepticus with favourable evolution in a teenager with FIRES: Is the association of vagus nerve stimulation and cannabidiol effective?
    Brain Dev. 2023 Jan 30:S0387-7604(23)00004.
    PubMed     Abstract available
    
    
    
29. KAWANO O, Saito T, Sumitomo N, Takeshita E, et al
    Skeletal anomaly and opisthotonus in early-onset epileptic encephalopathy with KCNQ2 abnormality.
    Brain Dev. 2023 Jan 9:S0387-7604(22)00221-2. doi: 10.1016/j.braindev.2022.
    PubMed     Abstract available
    
    
    December 2022
30. LI J, Zhou Y, Su T, Xu S, et al
    Perampanel therapy for intractable GRIN2D-related developmental and epileptic encephalopathy: A case report and literature review.
    Brain Dev. 2022 Dec 23:S0387-7604(22)00208.
    PubMed     Abstract available
    
    
    November 2022
31. OHTA K, Okanishi T, Kanai S, Nakamura Y, et al
    Stimulus-induced focal motor seizure in a pediatric patient with carbamazepine overdose.
    Brain Dev. 2022;44:765-768.
    PubMed     Abstract available
    
    
    October 2022
32. UEMATSU K, Matsumoto H, Zaha K, Mizuguchi M, et al
    Prediction and assessment of acute encephalopathy syndromes immediately after febrile status epilepticus.
    Brain Dev. 2022 Oct 31. pii: S0387-7604(22)00172.
    PubMed     Abstract available
    
    
    
33. HU Q, Luo Y, Li T, Ma J, et al
    Early-onset spontaneously relieved spasms of infancy in sleep: Electroclinical characteristics and differential diagnoses.
    Brain Dev. 2022;44:612-617.
    PubMed     Abstract available
    
    
    September 2022
34. SAGER SG, Turkyilmaz A, Gunbey HP, Karatoprak EY, et al
    A novel de novo TET3 loss-of-function variant in a Turkish boy presenting with neurodevelopmental delay and electrical status epilepticus during slow-wave sleep.
    Brain Dev. 2022 Sep 30. pii: S0387-7604(22)00163.
    PubMed     Abstract available
    
    
    
35. SUNAGA Y, Takayama Y, Yokosako S, Mizuno T, et al
    Drug-resistant temporal lobe epilepsy due to middle fossa meningoencephalocele in a child: A surgical case report.
    Brain Dev. 2022 Sep 14. pii: S0387-7604(22)00158.
    PubMed     Abstract available
    
    
    
36. MORIYAMA K, Mizuno T, Suzuki T, Inaji M, et al
    ATP1A3-related early childhood onset developmental and epileptic encephalopathy responding to corpus callosotomy: A case report.
    Brain Dev. 2022 Sep 13. pii: S0387-7604(22)00159.
    PubMed     Abstract available
    
    
    
37. HASHIMOTO K, Baba S, Nakagawa E, Sumitomo N, et al
    Long-term changes in electroencephalogram findings in a girl with a nonsense SMC1A variant: A case report.
    Brain Dev. 2022;44:551-557.
    PubMed     Abstract available
    
    
    
38. TAKEDA Y, Sakakibara T, Ogiwara K, Nogami K, et al
    Blood coagulation dynamics during adrenocorticotropic hormone therapy in pediatric patients with infantile spasms.
    Brain Dev. 2022;44:546-550.
    PubMed     Abstract available
    
    
    August 2022
39. SAITO M, Murai T, Motobayashi M, Ono S, et al
    Refractory status epilepticus with fever due to mumps vaccine-induced encephalitis caused secondary encephalopathy mimicking acute encephalopathy with biphasic seizures and late reduced diffusion.
    Brain Dev. 2022 Aug 24. pii: S0387-7604(22)00153.
    PubMed     Abstract available
    
    
    
40. GIACOMINI T, Scala M, Nobile G, Severino M, et al
    De novo POLR2A p.(Ile457Thr) variant associated with early-onset encephalopathy and cerebellar atrophy: expanding the phenotypic spectrum.
    Brain Dev. 2022;44:480-485.
    PubMed     Abstract available
    
    
    
41. D'ONOFRIO G, Riva A, Di Rosa G, Cali' E, et al
    Paroxysmal limb dystonias associated with GABBR2 pathogenic variant: A case-based literature review.
    Brain Dev. 2022;44:469-473.
    PubMed     Abstract available
    
    
    
42. KOMATSU K, Fukumura S, Minagawa K, Nakashima M, et al
    A new case of concurrent existence of PRRT2-associated paroxysmal movement disorders with c.649dup variant and 16p11.2 microdeletion syndrome.
    Brain Dev. 2022;44:474-479.
    PubMed     Abstract available
    
    
    July 2022
43. SAKATA Y, Nakamura T, Matsuo M
    Reply: Amnestic aphasia in MELAS can be epileptogenic.
    Brain Dev. 2022 Jul 7. pii: S0387-7604(22)00109.
    PubMed    
    
    
    June 2022
44. FINSTERER J
    Amnestic aphasia in MELAS can be epileptogenic.
    Brain Dev. 2022 Jun 14. pii: S0387-7604(22)00101.
    PubMed    
    
    
    
45. FUKUOKA M, Kuki I, Hattori Y, Tsuji H, et al
    A case of focal cortical dysplasia type IIa with pathologically suspected bilateral Rasmussen syndrome.
    Brain Dev. 2022;44:401-404.
    PubMed     Abstract available
    
    
    
46. KAWAKAMI S, Kubota M, Terashima H, Nagata C, et al
    Differentiating early clinical features of Panayiotopoulos syndrome from acute encephalopathy.
    Brain Dev. 2022;44:386-390.
    PubMed     Abstract available
    
    
    April 2022
47. IIMURA Y, Nakazawa M, Suzuki H, Mitsuhashi T, et al
    Surgery for intractable epilepsy after severe encephalopathy with reversible splenial lesion and new onset hippocampal lesion associated with parechovirus.
    Brain Dev. 2022 Apr 4. pii: S0387-7604(22)00049.
    PubMed     Abstract available
    
    
    March 2022
48. OHNO A, Okumura A, Fukasawa T, Nakata T, et al
    Acute encephalopathy with biphasic seizures and late reduced diffusion: Predictive EEG findings.
    Brain Dev. 2022;44:221-228.
    PubMed     Abstract available
    
    
    February 2022
49. OKANISHI T, Fujii Y, Sakuma S, Shiraishi H, et al
    Lacosamide monotherapy for the treatment of childhood epilepsy with centrotemporal spikes.
    Brain Dev. 2022 Feb 28. pii: S0387-7604(22)00024.
    PubMed     Abstract available
    
    
    
50. SAKATA Y, Sano K, Aoki S, Saitsu H, et al
    Neurochemistry evaluated by MR spectroscopy in a patient with SPTAN1-related developmental and epileptic encephalopathy.
    Brain Dev. 2022 Feb 23. pii: S0387-7604(22)00020.
    PubMed     Abstract available
    
    
    
51. KIKUCHI K, Hamano SI, Matsuura R, Nonoyama H, et al
    The effectiveness of intravenous benzodiazepine for status epilepticus in Dravet syndrome.
    Brain Dev. 2022 Feb 1. pii: S0387-7604(22)00006.
    PubMed     Abstract available
    
    
    
52. JHA R, Kurup A, Kovilapu UB, Ranjan R, et al
    Somatic mutations involving TSC 1 and TSC2 genes in two children with focal cortical dysplasia.
    Brain Dev. 2022;44:166-172.
    PubMed     Abstract available
    
    
    
53. GRABER D, Imagawa E, Miyake N, Matsumoto N, et al
    Polymicrogyria in a child with KCNMA1-related channelopathy.
    Brain Dev. 2022;44:173-177.
    PubMed     Abstract available
    
    
    
54. MATSUURA R, Hamano SI, Daida A, Horiguchi A, et al
    Serum matrix metallopeptidase-9 and tissue inhibitor of metalloproteinase-1 levels may predict response to adrenocorticotropic hormone therapy in patients with infantile spasms.
    Brain Dev. 2022;44:114-121.
    PubMed     Abstract available
    
    
    January 2022
55. TAHARA M, Higurashi N, Narita A, Ida H, et al
    Long-term efficacy of low-dose perampanel for progressive myoclonus epilepsy in a patient with Gaucher disease type 3.
    Brain Dev. 2022 Jan 3. pii: S0387-7604(21)00230.
    PubMed     Abstract available
    
    
    
56. HADI DA, Mohamed AR, Rethanavelu K, Khoo TB, et al
    Clonic seizures, continuous spikes-and-waves during slow sleep, choreoathetosis and response to sulthiame in a child with FRRS1L encephalopathy.
    Brain Dev. 2022;44:44-49.
    PubMed     Abstract available
    
    
    December 2021
57. CHEN J, Liu P, Hu W, Shi K, et al
    Absence seizures during sleep in childhood absence epilepsy: A sign of drug resistance?
    Brain Dev. 2021 Dec 9. pii: S0387-7604(21)00213.
    PubMed     Abstract available
    
    
    November 2021
58. CHAN DL, Rudinger-Thirion J, Frugier M, Riley LG, et al
    A case of QARS1 associated epileptic encephalopathy and review of epilepsy in aminoacyl-tRNA synthetase disorders.
    Brain Dev. 2021 Nov 10. pii: S0387-7604(21)00203.
    PubMed     Abstract available
    
    
    
59. NAKAMURA Y, Okanishi T, Yamada H, Okazaki T, et al
    Progressive cerebral atrophies in three children with COL4A1 mutations.
    Brain Dev. 2021;43:1033-1038.
    PubMed     Abstract available
    
    
    
60. BOUHADOUN S, Poulin C, Berrahmoune S, Myers KA, et al
    A retrospective analysis of memantine use in a pediatric neurology clinic.
    Brain Dev. 2021;43:997-1003.
    PubMed     Abstract available
    
    
    October 2021
61. YAMAGUCHI H, Nishiyama M, Tomioka K, Hongo H, et al
    Growth and differentiation factor-15 as a potential prognostic biomarker for status-epilepticus-associated-with-fever: A pilot study.
    Brain Dev. 2021 Oct 27. pii: S0387-7604(21)00187.
    PubMed     Abstract available
    
    
    
62. ONO-TAKIGUCHI Y, Muramatsu K, Koshu K, Yamagata T, et al
    Forced normalization of Lennox-Gastaut syndrome using lacosamide: A case report.
    Brain Dev. 2021;43:963-966.
    PubMed     Abstract available
    
    
    September 2021
63. KIRIKAE H, Uematsu M, Numata-Uematsu Y, Saijo N, et al
    Two types of early epileptic encephalopathy in a Pitt-Hopkins syndrome patient with a novel TCF4 mutation.
    Brain Dev. 2021 Sep 24. pii: S0387-7604(21)00174.
    PubMed     Abstract available
    
    
    
64. TAKAMI Y, Nakagawa T
    Risk of seizure recurrence after a first unprovoked seizure in childhood.
    Brain Dev. 2021;43:843-850.
    PubMed     Abstract available
    
    
    August 2021
65. KASHIKI T, Kido J, Momosaki K, Kusunoki S, et al
    Mitochondrial DNA depletion syndrome with a mutation in SLC25A4 developing epileptic encephalopathy: A case report.
    Brain Dev. 2021 Aug 25. pii: S0387-7604(21)00155.
    PubMed     Abstract available
    
    
    
66. ICHINOSE F, Nakamura T, Kira R, Furuno K, et al
    Incidence and risk factors of acute encephalopathy with biphasic seizures in febrile status epilepticus.
    Brain Dev. 2021 Aug 3. pii: S0387-7604(21)00132.
    PubMed     Abstract available
    
    
    July 2021
67. TAIRA R, Yamamura K, Maeda T, Sakata A, et al
    Paroxysmal sympathetic hyperactivity and the later development of epilepsy in a chemotherapy-associated brain damage.
    Brain Dev. 2021 Jul 20. pii: S0387-7604(21)00129.
    PubMed     Abstract available
    
    
    
68. COHEN H, Kramer U, Hausman-Kedem M, Uliel-Siboni S, et al
    Dosage of cannabidiol-enriched cannabis in children and adults with epilepsy.
    Brain Dev. 2021 Jul 2. pii: S0387-7604(21)00124.
    PubMed    
    
    
    June 2021
69. CHEN W, Qin J, Shen Y, Liang J, et al
    Next generation sequencing in children with unexplained epilepsy: A retrospective cohort study.
    Brain Dev. 2021 Jun 10. pii: S0387-7604(21)00103.
    PubMed     Abstract available
    
    
    
70. MATSUMOTO A, Kojima K, Miya F, Miyauchi A, et al
    Two cases of DYNC1H1 mutations with intractable epilepsy.
    Brain Dev. 2021 Jun 3. pii: S0387-7604(21)00094.
    PubMed     Abstract available
    
    
    
71. AZUMAGAWA K, Nakashima I, Kaneko K, Torisu H, et al
    A nation-wide survey of Japanese pediatric MOG antibody-associated diseases.
    Brain Dev. 2021;43:705-713.
    PubMed     Abstract available
    
    
    May 2021
72. HIRATA K, Sugawara Y, Hoshino A, Takeda S, et al
    Nonconvulsive status epilepticus following rotavirus gastroenteritis in two pediatric patients.
    Brain Dev. 2021 May 29. pii: S0387-7604(21)00098.
    PubMed     Abstract available
    
    
    
73. OKA M, Kobayashi K, Shibata T, Tsuchiya H, et al
    A study on the relationship between non-epileptic fast (40 - 200 Hz) oscillations in scalp EEG and development in children.
    Brain Dev. 2021 May 26. pii: S0387-7604(21)00091.
    PubMed     Abstract available
    
    
    
74. TIAN Q, Li H, Shu L, Wang H, et al
    Effective treatments for FGF12-related early-onset epileptic encephalopathies patients.
    Brain Dev. 2021 May 18. pii: S0387-7604(21)00088.
    PubMed     Abstract available
    
    
    
75. ZHANG Y, Ichinose F, Maeda T, Nakamura T, et al
    A pediatric case of transient periictal MRI abnormalities after repeated seizures.
    Brain Dev. 2021 May 3. pii: S0387-7604(21)00066.
    PubMed     Abstract available
    
    
    
76. SUZUKI Y, Ito S, Otani Y, Nishikawa A, et al
    Unexpected elevation in valproic acid concentration and agranulocytosis in a patient with short-chain acyl-CoA dehydrogenase deficiency.
    Brain Dev. 2021;43:657-660.
    PubMed     Abstract available
    
    
    
77. IZUMI T, Aihara Y, Kikuchi A, Kure S, et al
    Electroencephalographic findings and genetic characterization of two brothers with IQSEC2 pathogenic variant.
    Brain Dev. 2021;43:652-656.
    PubMed     Abstract available
    
    
    
78. YAMAMOTO N, Kuki I, Nagase S, Inoue T, et al
    A case of infantile Tay-Sachs disease with late onset spasms.
    Brain Dev. 2021;43:661-665.
    PubMed     Abstract available
    
    
    April 2021
79. KASRADZE S, Lomidze G, Cross JH, Kvernadze D, et al
    A six-year longitudinal study of neurocognitive problems in children with epilepsy.
    Brain Dev. 2021 Apr 20. pii: S0387-7604(21)00064.
    PubMed     Abstract available
    
    
    
80. OGUNI H, Ito S, Nishikawa A, Otani Y, et al
    Morphometric analysis of spike-wave complexes (SWCs) causing myoclonic seizures in children with idiopathic myoclonic epilepsies - A positive SWC component correlates with myoclonic intensity.
    Brain Dev. 2021 Apr 16. pii: S0387-7604(21)00058.
    PubMed     Abstract available
    
    
    
81. NEGISHI Y, Aoki Y, Itomi K, Yasuda K, et al
    SCN8A-related developmental and epileptic encephalopathy with ictal asystole requiring cardiac pacemaker implantation.
    Brain Dev. 2021 Apr 4. pii: S0387-7604(21)00061.
    PubMed     Abstract available
    
    
    March 2021
82. BATTAGLIA D, Chieffo D, Lucibello S, Marini C, et al
    Multicenter prospective longitudinal study in 34 patients with Dravet syndrome: Neuropsychological development in the first six years of life.
    Brain Dev. 2021;43:419-430.
    PubMed     Abstract available
    
    
    
83. KANATANI M, Adachi T, Sakata R, Nishimura Y, et al
    Dravet syndrome with parkinsonian symptoms and intact dopaminergic neurons: A case report.
    Brain Dev. 2021;43:486-489.
    PubMed     Abstract available
    
    
    February 2021
84. BAMBORSCHKE D, Kreutzer M, Koy A, Koerber F, et al
    PNPT1 mutations may cause Aicardi-Goutieres-Syndrome.
    Brain Dev. 2021;43:320-324.
    PubMed     Abstract available
    
    
    
85. GEIER DA, Geier MR
    A longitudinal cohort study of childhood MMR vaccination and seizure disorder among American children.
    Brain Dev. 2021;43:251-267.
    PubMed     Abstract available
    
    
    
86. YOO S, Kim YA, Yoon JY, Seo GH, et al
    The first Korean cases of combined oxidative phosphorylation deficiency 35 with two novel TRIT1 mutations in two siblings confirmed by clinical and molecular investigation.
    Brain Dev. 2021;43:325-330.
    PubMed     Abstract available
    
    
    
87. KIM HJ, Yang D, Kim SH, Won D, et al
    Clinical characteristics of KCNQ2 encephalopathy.
    Brain Dev. 2021;43:244-250.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Epilepsy is free of charge.